Structure Therapeutics Stock Forecast - Relative Strength Index
| GPCR Stock | 89.32 0.25 0.28% |
Structure Stock outlook is based on your current time horizon. Although Structure Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Structure Therapeutics' systematic risk associated with finding meaningful patterns of Structure Therapeutics fundamentals over time.
The RSI of Structure Therapeutics' share price is above 70 as of today. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Structure, making its price go up or down. Momentum 71
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (1.37) | EPS Estimate Next Year (1.38) | Wall Street Target Price 107.8 | EPS Estimate Current Quarter (0.37) |
Using Structure Therapeutics hype-based prediction, you can estimate the value of Structure Therapeutics American from the perspective of Structure Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Structure Therapeutics using Structure Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Structure using crowd psychology based on the activity and movement of Structure Therapeutics' stock price.
Structure Therapeutics Short Interest
An investor who is long Structure Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Structure Therapeutics and may potentially protect profits, hedge Structure Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 31.7043 | Short Percent 0.1141 | Short Ratio 2.66 | Shares Short Prior Month 4.9 M | 50 Day MA 58.4907 |
Structure Relative Strength Index
Structure Therapeutics Hype to Price Pattern
Investor biases related to Structure Therapeutics' public news can be used to forecast risks associated with an investment in Structure. The trend in average sentiment can be used to explain how an investor holding Structure can time the market purely based on public headlines and social activities around Structure Therapeutics American. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Structure Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Structure Therapeutics.
Structure Therapeutics Implied Volatility | 1.11 |
Structure Therapeutics' implied volatility exposes the market's sentiment of Structure Therapeutics American stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Structure Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Structure Therapeutics stock will not fluctuate a lot when Structure Therapeutics' options are near their expiration.
Structure Therapeutics after-hype prediction price | USD 76.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Structure | Build AI portfolio with Structure Stock |
Prediction based on Rule 16 of the current Structure contract
Based on the Rule 16, the options market is currently suggesting that Structure Therapeutics American will have an average daily up or down price movement of about 0.0694% per day over the life of the 2026-04-17 option contract. With Structure Therapeutics trading at USD 89.32, that is roughly USD 0.062 . If you think that the market is fully incorporating Structure Therapeutics' daily price movement you should consider acquiring Structure Therapeutics American options at the current volatility level of 1.11%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Structure Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Structure Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Structure Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Structure Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Structure Therapeutics' open interest, investors have to compare it to Structure Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Structure Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Structure. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Structure Therapeutics Additional Predictive Modules
Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 71.33 | 71.33 |
| Check Structure Therapeutics Volatility | Backtest Structure Therapeutics | Information Ratio |
Structure Therapeutics Trading Date Momentum
| On January 27 2026 Structure Therapeutics American was traded for 89.32 at the closing time. The top price for the day was 89.32 and the lowest listed price was 89.32 . There was no trading activity during the period 0.0. Lack of trading volume on January 27, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.28% . |
| Compare Structure Therapeutics to competition |
Other Forecasting Options for Structure Therapeutics
For every potential investor in Structure, whether a beginner or expert, Structure Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Structure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Structure. Basic forecasting techniques help filter out the noise by identifying Structure Therapeutics' price trends.Structure Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Structure Therapeutics stock to make a market-neutral strategy. Peer analysis of Structure Therapeutics could also be used in its relative valuation, which is a method of valuing Structure Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Structure Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 89.32 | |||
| Day Typical Price | 89.32 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.25) | |||
| Relative Strength Index | 71.33 |
Structure Therapeutics Risk Indicators
The analysis of Structure Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Structure Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting structure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.08 | |||
| Semi Deviation | 2.78 | |||
| Standard Deviation | 13.22 | |||
| Variance | 174.81 | |||
| Downside Variance | 13.35 | |||
| Semi Variance | 7.71 | |||
| Expected Short fall | (6.72) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Structure Therapeutics
The number of cover stories for Structure Therapeutics depends on current market conditions and Structure Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Structure Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Structure Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Structure Therapeutics Short Properties
Structure Therapeutics' future price predictability will typically decrease when Structure Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Structure Therapeutics American often depends not only on the future outlook of the potential Structure Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Structure Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.6 M | |
| Cash And Short Term Investments | 883.5 M |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.